Adhera Therapeutics, Inc. Proceeds from Convertible Debt
Adhera Therapeutics, Inc. reported Proceeds from Convertible Debt of $200.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2023-11-20
- Adhera Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2017-09-30 was $0.00.
- Adhera Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2016-12-31 was $74.97K.
- Adhera Therapeutics, Inc. proceeds from convertible debt for fiscal 2016 was $124.97K.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-20 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19 | $400.00K 10-Q · filed 2018-11-19 | ||
| 2017-06-30 | $400.00K 10-Q · filed 2018-08-10 | |||
| 2016-12-31 | $74.97K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | $124.97K 10-K · filed 2018-04-17 | ||
| 2016-09-30 | $50.00K 10-Q · filed 2017-11-13 |